Please use this identifier to cite or link to this item: https://doi.org/10.1007/s00134-012-2558-4
Title: Hyperbaric oxygen therapy in necrotising soft tissue infections: A study of patients in the United States Nationwide Inpatient Sample
Authors: Soh, C.R.
Pietrobon, R. 
Freiberger, J.J.
Chew, S.T.
Rajgor, D.
Gandhi, M.
Shah, J. 
Moon, R.E.
Keywords: Healthcare cost and utilisation project
Hyperbaric oxygen therapy
National inpatient sample
Necrotising soft tissue infections
Issue Date: Jul-2012
Citation: Soh, C.R., Pietrobon, R., Freiberger, J.J., Chew, S.T., Rajgor, D., Gandhi, M., Shah, J., Moon, R.E. (2012-07). Hyperbaric oxygen therapy in necrotising soft tissue infections: A study of patients in the United States Nationwide Inpatient Sample. Intensive Care Medicine 38 (7) : 1143-1151. ScholarBank@NUS Repository. https://doi.org/10.1007/s00134-012-2558-4
Abstract: Purpose: Necrotising soft tissue infection (NSTI) is a deadly disease associated with a significant risk of mortality and long-term disability from limb and tissue loss. The aim of this study was to determine the effect of hyperbaric oxygen (HBO 2) therapy on mortality, complication rate, discharge status/location, hospital length of stay and inflation-adjusted hospitalisation cost in patients with NSTI. Methods: This was a retrospective study of 45,913 patients in the Nationwide Inpatient Sample (NIS) from 1988 to 2009. Results: A total of 405 patients received HBO 2 therapy. The patients with NSTI who received HBO 2 therapy had a lower mortality (4.5 vs. 9.4 %, p = 0.001). After adjusting for predictors and confounders, patients who received HBO 2 therapy had a statistically significantly lower risk of dying (odds ratio (OR) 0.49, 95 % confidence interval (CI) 0.29-0.83), higher hospitalisation cost (US$52,205 vs. US$45,464, p = 0.02) and longer length of stay (LOS) (14.3 days vs. 10.7 days, p < 0.001). Conclusions: This retrospective analysis of HBO 2 therapy in NSTI showed that despite the higher hospitalisation cost and longer length of stay, the statistically significant reduction in mortality supports the use of HBO 2 therapy in NSTI. © 2012 Copyright jointly held by Springer and ESICM.
Source Title: Intensive Care Medicine
URI: http://scholarbank.nus.edu.sg/handle/10635/110115
ISSN: 03424642
DOI: 10.1007/s00134-012-2558-4
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

28
checked on Feb 21, 2020

WEB OF SCIENCETM
Citations

24
checked on Feb 13, 2020

Page view(s)

58
checked on Feb 22, 2020

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.